Transthoracic Echocardiography of the Superior Vena Cava in Intensive Care Units (ICU) Intubated Patients
CAVSUP
Transthoracic Echocardiographic Assessment of the Superior Vena Cava Flow Respiratory Variation in ICU Intubated Patients
1 other identifier
interventional
188
1 country
1
Brief Summary
Acute circulatory failure is frequent, affecting up to one-third of patients admitted to intensive care units (ICU). Monitoring hemodynamics and cardiac function is therefore a major concern. Analysis of respiratory diameter variations of the superior vena cava (SVC) is easily obtained with transesophageal echocardiography (TEE) and is helpful to assess fluid responsiveness. Transthoracic echocardiography (TTE) exploration of the SVC is not used in routine. Recently, micro-convex ultrasound transducers have been marketed and these may be of use for non-invasive SVC flow examination. However, analysis of diameter variations of the SVC with TTE does not seem to be possible since the approach from the supraclavicular fossa does not allow for a good visualization of the SVC walls. It was recently demonstrated in a short pilot study that TTE examination of the SVC flow with a micro-convex ultrasound transducer (GE 8C-RS) seems both easy to learn and to use (feasibility = 84.9%), and is reproducible in most ventilated ICU patients with an intraclass correlation coefficient for the systolic fraction of the superior vena cava flow of 0.90 (95% confidence interval \[0.86-0.93\]). The hypothesis is that cardio-respiratory interactions in intubated-ventilated patients are responsible of SVC flow variations and that the analysis of the SVC flow respiratory variations could be a new predictive tool of fluid responsiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2018
CompletedFirst Posted
Study publicly available on registry
April 25, 2018
CompletedStudy Start
First participant enrolled
May 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2020
CompletedMay 31, 2018
May 1, 2018
2 years
April 16, 2018
May 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ventricular outflow tract velocity time index (LVOT TVI)
Echo-Doppler measurements are performed with Vivid S6 model (GE Healthcare France, Lyon, France). All measurements are recorded at the end of expiration. Echo-Doppler measurements are performed in the upper part of the SVC, approximately 1 to 2 cm below the brachiocephalic vein. From this view, pulse Doppler is performed. Pulse Doppler waves obtained in the SVC are used to obtain velocity time integrals (VTI). Expiratory VTI is named VTImax and inspiratory VTI is named VTImin. These values will allow the calculation of Respiratory variations of the superior vena cava flow (ΔSVCf). ΔSVCf is calculated as(VTImax- VTImin )/(1/2(VTImax+ VTImin))
The day of inclusion
Secondary Outcomes (2)
optimal cut-off value of ΔSVCf to predict fluid-responsiveness
The day of inclusion
proportion of patients in which measurement of ΔSVCf is not possible
The day of inclusion
Study Arms (1)
ICU intubated patients
EXPERIMENTALAfter inclusion, Echo-Doppler measurements are performed with Vivid S6 model (GE Healthcare France, Lyon, France). The left ventricular outflow tract velocity time index (LVOT TVI) will be measured with this device. Then, a passive leg raising (PLR) will be performed and finally LVOT VTI will be measured again after PLR Patients will be classified in two groups according to the hemodynamic response to PLR : * Patients are responders if LVOT VTI increases of at least 10% after PLR * patients are non-responders if LVOT VTI does not increase or increase of less than 10% after PLR.
Interventions
PLR is a test that predicts whether cardiac output will increase with volume expansion. By transferring a volume of around 300 mL of venous blood from the lower body toward the right heart, PLR mimics a fluid challenge. However, no fluid is infused and the hemodynamic effects are rapidly reversible, thereby avoiding the risks of fluid overload. PLR starts from the semi-recumbent and not the supine position. PLR is performed by adjusting the bed and not by manually raising the patient's legs
Echo-Doppler measurements are performed with Vivid S6 model (GE Healthcare France, Lyon, France). All measurements are recorded at the end of expiration. Echo-Doppler measurements are performed in the upper part of the SVC, approximately 1 to 2 cm below the brachiocephalic vein. From this view, pulse Doppler is performed. Pulse Doppler waves obtained in the SVC are used to obtain velocity time integrals (VTI). Expiratory VTI is named VTImax and inspiratory VTI is named VTImin. These values will allow the calculation of Respiratory variations of the superior vena cava flow (ΔSVCf). ΔSVCf is calculated as (VTImax- VTImin )/(1/2(VTImax+ VTImin)).
Eligibility Criteria
You may qualify if:
- Adult patients (≥ 18 years old)
- Admission in ICU after tracheal intubation or tracheal intubation during the ICU stay
- Volume-controlled ventilation with a tidal volume of 8 mL/kg
You may not qualify if:
- Persistence of spontaneous breathing
- Cardiac arrhythmia
- Severe Acute Respiratory Distress Syndrome, defined as PaO2/FIO2 ratio \< 100
- Acute right ventricular failure defined by S'VD \< 10 cm or Tricuspid Annular Plane Systolic Excursion (TAPSE) \< 10 mm measured with Transthoracic Echocardiography (TTE)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Département d'Anesthésie-Réanimation, Hôpital Edouard Herriot,
Lyon, 69003, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2018
First Posted
April 25, 2018
Study Start
May 25, 2018
Primary Completion
May 25, 2020
Study Completion
May 25, 2020
Last Updated
May 31, 2018
Record last verified: 2018-05